Zilretta meets primary endpoint in pivotal phase III trial in patients with knee osteoarthritis Feb. 17, 2016
FDA recommends approval of Celltrion's infliximab biosimilar, Epirus advances own biosimilar Feb. 10, 2016
Cosentyx available in U.S. for treatment of ankylosing spondylitis and psoriatic arthritis Jan. 21, 2016
RSS